Vectura Group Share Price (VEC)

178.00 -0.50 (-0.28%) delayed: 9:29AM GMT
Bid price 177.50 Open price 177.00
Ask price 178.50 Prev close 178.50
High price 178.60 Spread 0.56%
Low price 177.00 Volume 43,687

Register now for FREE live Vectura Group share prices, Vectura Group stock quotes, charts, trades market news and much much more. Why not upgrade to a premium service and get Vectura Group Level 2 Data, indepth research tools and investor commentary for Vectura Group (VEC) and other London Stock Exchange equities.

Vectura Group Share Price Chart

Advanced Charts >>

Register now for FREE Vectura Group share price charts

Vectura Group Share Price Information

Name Vectura Group Epic VEC
Sector Pharmaceuticals & Biotechnology ISIN GB00B01D1K48
Activites Vectura Group plc develops inhaled therapies principally for the treatment of respiratory diseases. Vectura's main products target diseases such as asthma and chronic obstructive pulmonary disease (COPD), a growing market that is currently estimated to be worth in excess of $25bn. Vectura has seven products marketed by its partners and a portfolio of drugs in clinical and pre-clinical development, a number of which have been licensed to major pharmaceutical companies. Vectura has development collaborations and licence agreements with several pharmaceutical companies, including Novartis, Sandoz (the generics arm of Novartis), Baxter and GlaxoSmithKline (GSK). Vectura seeks to develop certain programmes itself where this will optimise value. Vectura's formulation and inhalation technologies are available to other pharmaceutical companies on an out-licensing basis where this complements Vectura's business strategy. Index FTSE 250

Vectura Group Key Numbers

Latest Share Price (p) 178.00 Net Gearing (%) -6.27
Market Capitalisation (£m) 720.24 Gross Gearing (%) 24.40
Shares in issue (m) 404.52 Debt Ratio 10.20
P/E Ratio 197.83 Debt-to-Equity Ratio 0.35
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.32
Dividend Yield (%) 0.00 Price to book value 3.25
Dividend cover (x) 0.00 ROCE (%) -2.51
Earning per share (p) 0.90 EPS Growth (%) 228.57
52 week high / low 200.00 / 140.00 DPS Growth (%) n/a

Vectura Group Director Deals

Dec.Date Type Director Pos No. of Shares
05/10/2015 TIN Dr Trevor Phillips ED 205,329
07/07/2015 BUY Dr Trevor Phillips ED 1,000
07/07/2015 BUY Andrew Oakley FD 1,000
17/04/2015 EXR Dr Christopher Blackwell RES 18,987
16/01/2015 EXR Dr Trevor Phillips ED 3,133

More Vectura Group Director Deals >>

Vectura Group Company News

12:36 08/02/2016

Holding(s) in Company

/* */ RNS Number : 3970O Vectura Group plc 08 February 2016     For filings with the FCA include the annex For filings with issuer exclude the annex TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES...

10:40 04/02/2016

Broker Forecast - Numis issues a broker note on Vectura Group PLC

Numis today reaffirms its buy investment rating on Vectura Group PLC (LON:VEC) and set its price target at 271p. Story provided by

10:58 01/02/2016

Total Voting Rights

/* */ RNS Number : 6239N Vectura Group plc 01 February 2016         Vectura Group plc (the "Company")   VOTING RIGHTS AND CAPITAL     Chippenham, UK, 1 February 2016: In accordance with the Financial...

More Vectura Group Company News >>

Register now for FREE Vectura Group company news

Vectura Group Share Price Discussions

11 months ago


Powered by IST's

Register now for FREE Vectura Group share price discussions